HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
Drug Discovery Strategies To Fight COVID-19
  • Chloroquine & Hydroxychloroquine: COVID-19
  • Pharmacology & Therapeutics in pregnancy with COVID-19

Chloroquine and Hydroxychloroquine is an antimalarial, disease-modifying anti-rheumatic drug. In China and France, some studies provided some indications of possible benefits against pneumonia caused by COVID-19 but need confirmation through randomized trials.

There are many trials going on now to test the efficacy of these drugs. Mechanism of action of hydroxychloroquine includes multiple effects including reduced cytokine production, inhibits immune activation and also interferes with lysosomal activity and membrane stability.

Chloroquine was discovered in 1934 by Hans AndersagIt is usually available as a generic medication. Common side effects include muscle problems, loss of appetite, diarrhoea, and skin rash and serious side effects include problems with vision, muscle damage, seizures, and low blood cell levels. It is a member of the drug class 4-aminoquinoline.

During pregnancy, a woman undergoes with multiple interactions with the health care system that increases her chance of getting infected. So therefore, managing pregnant population presents a unique challenge during COVID-19. The physiological changes and partial immune suppression during pregnancy makes pregnant women and new-born babies susceptible to several infections. Post-partum haemorrhage, maternal sepsis, preeclampsia, and premature rupture of membrane are the most common COVID-19-induced adverse events reported among pregnant women.

Committee Members
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - A C Matin

A C Matin

Stanford University, United States
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Miroslav Radenkovic

Miroslav Radenkovic

University of Belgrade, Serbia
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Andreia Freitas

Andreia Freitas

INIAV and REQUIMTE, Portugal
PDDS 2023 Speakers
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Wayne Kaesemeyer

Wayne Kaesemeyer

Augusta Hypertension PC, United States
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Richard Z. Cheng

Richard Z. Cheng

Cheng Integrative Health Center, United States
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Mario souza y machorro

Mario souza y machorro

International College of Superior Education, Mexico
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Gurpreet Singh

Gurpreet Singh

Freyr Lifesciences Limited, United Kingdom
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Liberata Sportiello

Liberata Sportiello

University of Campania “L. Vanvitelli”, Italy
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Franz Josef Meyer Almes

Franz Josef Meyer Almes

University of Applied Sciences, Germany

Submit your abstract Today

Watsapp